Suppr超能文献

肥胖、肥胖相关代谢状况与女性甲状腺癌风险:一项前瞻性队列研究(姐妹研究)的结果

Obesity, obesity-related metabolic conditions, and risk of thyroid cancer in women: results from a prospective cohort study (Sister Study).

作者信息

Pasqual Elisa, O'Brien Katie, Rinaldi Sabina, Sandler Dale P, Kitahara Cari M

机构信息

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, 20892, USA.

International Agency for Research on Cancer, 25 Avenue Tony Garnier, CS 90627, 69366 Lyon CEDEX 07, France.

出版信息

Lancet Reg Health Am. 2023 Jun 14;23:100537. doi: 10.1016/j.lana.2023.100537. eCollection 2023 Jul.

Abstract

BACKGROUND

Thyroid cancer incidence has increased worldwide. Obesity trends may play a role, but the underlying biological pathways are not well-characterized. Therefore, we examined associations of excess adiposity and obesity-related metabolic conditions with thyroid cancer incidence.

METHODS

From the Sister Study, a cohort of sisters of women with breast cancer, we included 47,739 women who were cancer-free at baseline (2003-2009). Height, weight, waist and hip circumference, and blood pressure were measured at baseline and medical history was self-reported. Cox proportional hazards regression models were adjusted for age (time scale), race/ethnicity, smoking, baseline history of benign thyroid disease, and frequency of routine healthcare visits.

FINDINGS

During follow-up (median = 12.5; max = 15.9 years), 259 women reported incident thyroid cancer. Body mass index (BMI) (hazard ratio [HR] = 1.25, 95% CI = 1.14-1.37), waist circumference (HR = 1.11, 95% CI = 1.06-1.15), and waist-to-hip ratio (HR  = 1.49, 95% CI = 1.14-1.94) were positively associated with thyroid cancer incidence, as were metabolic syndrome (HR = 1.67, 95% CI = 1.24-2.25), dyslipidemia (HR = 1.46, 95% CI = 1.13-1.90), borderline diabetes (HR = 2.06, 95% CI = 1.15-3.69), hypertension (HR = 1.49, 95% CI = 1.12-1.96), and polycystic ovary syndrome (PCOS, HR = 2.10, 95% CI = 1.20-3.67). These associations were attenuated with additional BMI adjustment, although dyslipidemia (HR = 1.35, 95% CI = 1.04-1.75) and PCOS (HR = 1.86, 95% CI = 1.06-3.28) remained associated with thyroid cancer incidence. Hypothyroidism was not associated with thyroid cancer.

INTERPRETATION

In this cohort of sisters of women diagnosed with breast cancer, excess adiposity and several obesity-related metabolic conditions were associated with thyroid cancer incidence. These findings provide insights into potential biological mechanisms linking obesity and thyroid cancer.

FUNDING

This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute and National Institute of Environmental Health Sciences (Z01-ES044005).

摘要

背景

全球甲状腺癌发病率呈上升趋势。肥胖趋势可能起了一定作用,但其潜在的生物学途径尚未完全明确。因此,我们研究了超重肥胖及肥胖相关代谢状况与甲状腺癌发病率之间的关联。

方法

从“姐妹研究”(一项针对乳腺癌女性患者姐妹的队列研究)中,我们纳入了47739名在基线期(2003 - 2009年)无癌症的女性。在基线期测量身高、体重、腰围、臀围和血压,并由受试者自行报告病史。Cox比例风险回归模型根据年龄(时间尺度)、种族/民族、吸烟情况、良性甲状腺疾病的基线病史以及常规医疗就诊频率进行了调整。

结果

在随访期间(中位数 = 12.5年;最长 = 15.9年),259名女性报告患了甲状腺癌。体重指数(BMI)(风险比[HR] = 1.25,95%置信区间[CI] = 1.14 - 1.37)、腰围(HR = 1.11,95% CI = 1.06 - 1.15)和腰臀比(HR = 1.49,95% CI = 1.14 - 1.94)与甲状腺癌发病率呈正相关,代谢综合征(HR = 1.67,95% CI = 1.24 - 2.25)、血脂异常(HR = 1.46,95% CI = 1.13 - 1.90)、临界糖尿病(HR = 2.06,95% CI = 1.15 - 3.69)、高血压(HR = 1.49,95% CI = 1.12 - 1.96)和多囊卵巢综合征(PCOS,HR = 2.10,95% CI = 1.20 - 3.67)也与之相关。尽管进行了额外的BMI调整,这些关联有所减弱,但血脂异常(HR = 1.35,95% CI = 1.04 - 1.75)和PCOS(HR = 1.86,95% CI = 1.06 - 3.28)仍与甲状腺癌发病率相关。甲状腺功能减退与甲状腺癌无关。

解读

在这个被诊断患有乳腺癌女性的姐妹队列中,超重肥胖及几种肥胖相关代谢状况与甲状腺癌发病率相关。这些发现为连接肥胖与甲状腺癌的潜在生物学机制提供了见解。

资助

本研究由美国国立卫生研究院、国立癌症研究所和国立环境卫生科学研究所的内部研究项目资助(Z01 - ES044005)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f556/10279535/3d99091ae753/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验